-
1
-
-
80054944901
-
Role of the commensal microbiota in normal and pathogenic host immune responses
-
Littman DR, Pamer EG. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011; 10:311-323.
-
(2011)
Cell Host Microbe
, vol.10
, pp. 311-323
-
-
Littman, D.R.1
Pamer, E.G.2
-
2
-
-
84861980130
-
Interactions betweenthe microbiota and the immune system
-
Hooper LV, Littman DR, Macpherson AJ. Interactions betweenthe microbiota and the immune system. Science 2012; 336:1268-1273.
-
(2012)
Science
, vol.336
, pp. 1268-1273
-
-
Hooper, L.V.1
Littman, D.R.2
MacPherson, A.J.3
-
4
-
-
84870880811
-
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
-
Hartmann P, Chen WC, Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol 2012; 3:402.
-
(2012)
Front Physiol
, vol.3
, pp. 402
-
-
Hartmann, P.1
Chen, W.C.2
Schnabl, B.3
-
5
-
-
84874115025
-
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease
-
Yan AW, Schnabl B. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 2012; 4:110-118.
-
(2012)
World J Hepatol
, vol.4
, pp. 110-118
-
-
Yan, A.W.1
Schnabl, B.2
-
6
-
-
84856350648
-
Role of innate immunity and the microbiota in liver fibrosis: Crosstalk between the liver and gut
-
Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol 2012; 590:447-458.
-
(2012)
J Physiol
, vol.590
, pp. 447-458
-
-
Seki, E.1
Schnabl, B.2
-
7
-
-
78649908827
-
The role of the gut microbiota in nonalcoholic fatty liver disease
-
Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010; 7:691-701.
-
(2010)
Nat Rev Gastroenterol Hepatol
, vol.7
, pp. 691-701
-
-
Abu-Shanab, A.1
Quigley, E.M.2
-
8
-
-
79953730943
-
Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients
-
Lu H, Wu Z, Xu W, et al. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol 2011; 61:693-703.
-
(2011)
Microb Ecol
, vol.61
, pp. 693-703
-
-
Lu, H.1
Wu, Z.2
Xu, W.3
-
9
-
-
79960714764
-
Characterization of fecal microbial communities in patients with liver cirrhosis
-
Chen Y, Yang F, Lu H, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011; 54:562-572.
-
(2011)
Hepatology
, vol.54
, pp. 562-572
-
-
Chen, Y.1
Yang, F.2
Lu, H.3
-
11
-
-
84866396844
-
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
-
Bajaj JS, Hylemon PB, Ridlon JM, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012; 303:G675-G685.
-
(2012)
Am J Physiol Gastrointest Liver Physiol
, vol.303
-
-
Bajaj, J.S.1
Hylemon, P.B.2
Ridlon, J.M.3
-
12
-
-
80053618114
-
Linking long-term dietary patterns with gut microbial enterotypes
-
Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334:105-108.
-
(2011)
Science
, vol.334
, pp. 105-108
-
-
Wu, G.D.1
Chen, J.2
Hoffmann, C.3
-
13
-
-
78751537350
-
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
-
Yan AW, Fouts DE, Brandl J, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011; 53:96-105.
-
(2011)
Hepatology
, vol.53
, pp. 96-105
-
-
Yan, A.W.1
Fouts, D.E.2
Brandl, J.3
-
14
-
-
84861192672
-
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
-
Fouts DE, Torralba M, Nelson KE, et al. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J Hepatol 2012; 56:1283-1292.
-
(2012)
J Hepatol
, vol.56
, pp. 1283-1292
-
-
Fouts, D.E.1
Torralba, M.2
Nelson, K.E.3
-
15
-
-
84856407574
-
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis
-
Kalambokis GN, Tsianos EV. Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis. Hepatology 2012; 55:655-656.
-
(2012)
Hepatology
, vol.55
, pp. 655-656
-
-
Kalambokis, G.N.1
Tsianos, E.V.2
-
16
-
-
83355172756
-
The role of the gut barrier function in the pathophysiology of viral liver cirrhosis
-
Choi Y, Jeon WK, Hwang SJ, et al. The role of the gut barrier function in the pathophysiology of viral liver cirrhosis. Hepatogastroenterology 2011; 58: 1244-1247.
-
(2011)
Hepatogastroenterology
, vol.58
, pp. 1244-1247
-
-
Choi, Y.1
Jeon, W.K.2
Hwang, S.J.3
-
17
-
-
84858282462
-
Altered intestinal tight junctions' expression in patients with liver cirrhosis: A pathogenetic mechanism of intestinal hyperpermeability
-
Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, et al. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Invest 2012; 42:439-446.
-
(2012)
Eur J Clin Invest
, vol.42
, pp. 439-446
-
-
Assimakopoulos, S.F.1
Tsamandas, A.C.2
Tsiaoussis, G.I.3
-
18
-
-
80053606297
-
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection
-
1230e1-e3
-
Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastro-enterology 2011; 141:1220-1230; 1230e1-e3.
-
(2011)
Gastro-enterology
, vol.141
, pp. 1220-1230
-
-
Sandler, N.G.1
Koh, C.2
Roque, A.3
-
19
-
-
84856957894
-
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
-
Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482:179-185.
-
(2012)
Nature
, vol.482
, pp. 179-185
-
-
Henao-Mejia, J.1
Elinav, E.2
Jin, C.3
-
20
-
-
80052477222
-
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
-
Gabele E, Dostert K, Hofmann C, et al. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 2011; 55:1391-1399.
-
(2011)
J Hepatol
, vol.55
, pp. 1391-1399
-
-
Gabele, E.1
Dostert, K.2
Hofmann, C.3
-
21
-
-
84868136560
-
Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor i contribute to liver fibrosis in mice
-
e1
-
Hartmann P, Haimerl M, Mazagova M, et al. Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Gastroenterology 2012; 143:1330-1340; e1.
-
(2012)
Gastroenterology
, vol.143
, pp. 1330-1340
-
-
Hartmann, P.1
Haimerl, M.2
Mazagova, M.3
-
22
-
-
84859157275
-
Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense
-
Teltschik Z, Wiest R, Beisner J, et al. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 2012; 55:1154-1163.
-
(2012)
Hepatology
, vol.55
, pp. 1154-1163
-
-
Teltschik, Z.1
Wiest, R.2
Beisner, J.3
-
23
-
-
80054122238
-
The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine
-
Vaishnava S, Yamamoto M, Severson KM, et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011; 334:255-258.
-
(2011)
Science
, vol.334
, pp. 255-258
-
-
Vaishnava, S.1
Yamamoto, M.2
Severson, K.M.3
-
24
-
-
84867192879
-
Intestinal inflammation targets cancer-inducing activity of the microbiota
-
Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338: 120-123.
-
(2012)
Science
, vol.338
, pp. 120-123
-
-
Arthur, J.C.1
Perez-Chanona, E.2
Muhlbauer, M.3
-
25
-
-
79952316380
-
Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency
-
Spencer MD, Hamp TJ, Reid RW, et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011; 140:976-986.
-
(2011)
Gastroenterology
, vol.140
, pp. 976-986
-
-
Spencer, M.D.1
Hamp, T.J.2
Reid, R.W.3
-
26
-
-
79952749979
-
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
-
Swann JR, Want EJ, Geier FM, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 2011; 108 (Suppl 1):4523-4530.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, Issue.SUPPL. 1
, pp. 4523-4530
-
-
Swann, J.R.1
Want, E.J.2
Geier, F.M.3
-
27
-
-
79959396339
-
Bile retinoids imprint intestinal CD103 dendritic cells with the ability to generate gut-tropic T cells
-
Jaensson-Gyllenback E, Kotarsky K, Zapata F, et al. Bile retinoids imprint intestinal CD103 dendritic cells with the ability to generate gut-tropic T cells. Mucosal Immunol 2011; 4:438-447.
-
(2011)
Mucosal Immunol
, vol.4
, pp. 438-447
-
-
Jaensson-Gyllenback, E.1
Kotarsky, K.2
Zapata, F.3
-
28
-
-
84873296091
-
Characterization of the gut microbiome in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
-
Zhu L, Baker SS, Gill C, et al. Characterization of the gut microbiome in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013; 57:601-609.
-
(2013)
Hepatology
, vol.57
, pp. 601-609
-
-
Zhu, L.1
Baker, S.S.2
Gill, C.3
-
29
-
-
84866738529
-
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome
-
Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143:913-916.
-
(2012)
Gastroenterology
, vol.143
, pp. 913-916
-
-
Vrieze, A.1
Van Nood, E.2
Holleman, F.3
|